Sign Up NowThis Month's Tiny Gems - November 2011

Fuel Tech, Inc. (FTEK)
IsoRay, Inc. (ISR)
Procera Networks, Inc. (PKT)

 

 

 

Fuel Tech, Inc. (FTEK)

 

Fuel Tech, Inc. (FTEK), a leading technology company, is focused on the development, commercialization and application of state-of-the-art proprietary technologies for air pollution control, process optimization, and advanced engineering services. These technologies enable customers around the globe to cost effectively produce both energy and processed materials in an environmentally sustainable manner.

 

The Company's nitrogen oxide (NOx) reduction technologies include advanced combustion modification techniques - such as Low NOx Burners and Over-Fire Air systems - and post-combustion NOx control approaches, including NOxOUT® and HERT™ SNCR systems as well as systems that incorporate ASCR™ (Advanced Selective Catalytic Reduction), CASCADE™, ULTRA™ and NOxOUT-SCR® processes. Fuel Tech has leveraged these technologies to become a respected a leader in NOx reduction, with installations on over 640 units worldwide.

 

The Company's FUEL CHEM® technology is based on using chemicals to improve the efficiency, reliability, fuel flexibility and environmental status of combustion units by controlling slagging, fouling, corrosion, opacity and operational issues associated with sulfur trioxide, ammonium bisulfate, particulate matter (PM2.5), carbon dioxide and NOx. The Company has experience with this technology, in the form of a customizable FUEL CHEM program, on over 110 combustion units burning a wide variety of fuels including coal, heavy oil, biomass, and municipal waste.

 

Fuel Tech also offers an array of combustion optimization services, including airflow testing, coal flow testing and boiler tuning, in addition to services that help optimize selective catalytic reduction system performance, including catalyst management services and ammonia injection grid tuning. Flow corrective devices and physical and computational modeling services are also provided to optimize flue gas distribution.

 

 

 

IsoRay, Inc. (ISR)

 

IsoRay, Inc. (ISR) is utilizing its patented radioisotope technology, experienced chemists and engineers, and management team to create a medical device company focused on providing improved patient outcomes in the treatment of prostate cancer, lung cancer, ocular melanoma cancer, brain cancer, colorectal cancer, gynecological cancer, and other cancers throughout the body. Through its subsidiary, IsoRay Medical, the Company is the sole producer of FDA-cleared Cesium-131 brachytherapy seeds.

 

IsoRay began production and sales of Cesium-131 brachytherapy seeds in October 2004. The Company is leveraging its technology to capture a leadership position in an expanded brachytherapy market. The more clinically beneficial characteristics of the Cesium-131 isotope are expected to decrease radiation exposure to the patient and reduce the severity and duration of side effects, while treating cancer cells as effectively, if not more so, than Iodine-125 or Palladium-103.

 

In recent news, IsoRay announced that doctors have performed the world's first treatment of metastasized brain cancer using its Cesium-131 brachytherapy seeds. The seeds were implanted directly into a woman's brain to treat a cancer that had originated in the breast. Treatment of metastasized cancers, cancers that originate in other organs, is the latest application of IsoRay's brachytherapy treatment that represents one of the most important advancements in internal radiation therapy in the last 20 years.

 

IsoRay CEO Dwight Babcock emphasized that this treatment is only the beginning, predicting that the adoption of Cesium-131 for the treatment of primary and metastasized cancers will continue growing and gain momentum as the medical community becomes aware of the significant advantages it offers in treating cancer sites throughout the body. The pioneering treatment increases life expectancy and limits the potential of recurrence, while improving quality of life and allowing patients to return to normal activities more quickly.

 

 

 

Procera Networks, Inc. (PKT)

 

Procera Networks, Inc. (PKT) is focused on delivering Intelligent Policy Enforcement (IPE) solutions, using advanced Deep Packet Inspection (DPI) technology, to enable carriers, services providers and higher education institutions to improve the quality and lifetime of their networks. By utilizing Procera's solutions, organizations are able to better monetize their infrastructure investments, control hazards, and create attractive services for their users.

 

Procera's core product suite, the PacketLogic line of platforms, drives the PCC (Policy and Charging Control) ecosystem by enforcing advanced network and service policies. As of last report, PacketLogic has been deployed for more than 600 customers who have come to value the superior accuracy and high-end performance of the PacketLogic solution.

 

Applicable across all network and access technologies, PacketLogic enlightens cable MSOs of the impact on their core business from OTT video services, helps 3G operators identify and manage backhaul congestion, applies fair-share on shared-media WIMAX networks, implements tiered services on high-speed LTE networks, and helps xDSL and FTTH operators better understand their customers.

 

Procera recently announced that it will be providing two new Tier-1 fixed/mobile operators in the Asia Pacific region with subscriber awareness, location awareness and congestion management. The two operators have fixed and mobile assets with more than 40 million subscribers. According to the press release, Procera's ability to serve both networks with a single solution was a major factor in the selection process, not to mention the company's extensive reporting capabilities, BGP peering control and IPv6 support.